News

R.T.R.+ Membrane: the new resorbable bilayer synthetic membrane

Published March 30th, 2023

As a pharmaceutical company specialized in dentistry, Septodont’s aim is to support every dentist to succeed in their daily procedures. Our mission is to provide our customers with dental products and services that are unsurpassed in meeting their expectations for quality and performance.



To pursue our mission, we recently acquired Biomedical Tissue, a company at the forefront of tissue engineering which designs and produces membranes for tissue regeneration.



Septodont is happy to introduce today R.T.R.+ Membrane, the unique resorbable synthetic membrane designed to improve post-extraction procedures.



After a tooth extraction, approximately 30% of the alveolar ridge is lost because of resorption¹. Using a membrane improves the amount, quality, and contour of the desired bone.



  1. Thanks to years of research leading to a patented technology, R.T.R.+ Membrane is the first resorbable membrane composed of 100% vegetal-based polymer, making it effective and easy to handle. It is the perfect addition to the bone graft R.T.R.+ for a successful, synthetic procedure.
  2. With a resorption time of 4 to 6 months and a bilayer structure, R.T.R.+ Membrane is highly effective within an appropriate time frame for bone regeneration.
  3. R.T.R.+ Membrane has a great resistance to exposure. In case of suture rupture, it can be left in place to guide tissues to heal properly.
  4. R.T.R.+ Membrane is compatible with every bone graft and available in 4 sizes.






1 Hsi Kuei Lin, Yu Hwa Pan, Eisner Salamanca, Yu Te Lin 5 and Wei Jen Chang. Int. J. Environ. Res. Public Health 2019, 16, 4616; Prevention of Bone Resorption by HA/β-TCP + Collagen Composite after Tooth Extraction: A Case Series.

Discover more

By visiting our local websites

Click here

Other news you may be interested in

All news
Events

January 10th, 2025

Septodont Global Pulp Summit: the first event ever dedicated to biomaterials

December 19th, 2024

Septodont invests in Balanced Pharma

December 3th, 2024

Septodont receives the World Economic Forum 2024 New Champions award

All news